09/17/2020
3:20 PM | KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2020
3:18 PM | Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2020
3:16 PM | Curran Terrie (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2020
3:15 PM | GUINAN MARK (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2020
3:14 PM | Gulfo Adele M. (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2020
3:13 PM | Myovant Sciences (Issuer)
POTTER MYRTLE S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2020
3:12 PM | Myovant Sciences (Issuer)
Sebelius Kathleen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2020
3:05 PM | Myovant Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2020
3:47 PM | Lang Matthew (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/02/2020
3:42 PM | Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/01/2020
3:37 PM | KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2020
4:41 PM | Lang Matthew (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2020
4:07 PM | KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2020
4:04 PM | Lang Matthew (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2020
4:02 PM | Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2020
7:36 AM | Myovant Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2020
7:33 AM | Myovant Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2020
11:15 PM | Myovant Sciences (Filer)
| Form EFFECT
| |
07/24/2020
3:07 PM | Myovant Sciences (Filer)
| Form DEFA14A
| |
07/24/2020
3:03 PM | Myovant Sciences (Filer)
| Form DEF 14A
| |
06/26/2020
3:23 PM | Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2020
3:16 PM | Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2020
12:25 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
2:13 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
5:05 AM | Myovant Sciences (Filer)
| Form POS AM
| |
05/18/2020
3:20 PM | Myovant Sciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
05/18/2020
3:08 PM | Myovant Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2020
10:07 AM | Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
| Form SC 13D/A
| |
05/14/2020
8:57 PM | Myovant Sciences (Filer)
| Form POSASR
| |
05/13/2020
5:50 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2020
3:07 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4/A
| |
05/11/2020
3:01 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2020
8:00 AM | Myovant Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2020
2:40 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2020
4:35 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/27/2020
10:30 AM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2020
1:21 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2020
5:08 AM | Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
| Form SC 13D/A
| |
04/15/2020
6:22 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/13/2020
1:25 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2020
10:20 AM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
4:16 PM | Myovant Sciences (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
4:14 PM | Myovant Sciences (Issuer)
Sablich Kim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
4:12 PM | Lang Matthew (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
4:10 PM | KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
4:08 PM | Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
12:56 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2020
2:04 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2020
9:55 AM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/30/2020
10:34 AM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2020
12:11 PM | Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
| Form SC 13D/A
| |
03/26/2020
10:39 AM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2020
2:15 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2020
1:10 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2020
3:21 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2020
3:13 PM | Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
| Form SC 13D/A
| |
02/24/2020
5:38 PM | Gulfo Adele M. (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
2:20 PM | JANUS HENDERSON GROUP PLC (Filed by)
Myovant Sciences (Subject)
| Form SC 13G
| |
02/10/2020
7:44 AM | Myovant Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/10/2020
7:40 AM | Myovant Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2020
5:16 AM | Myovant Sciences (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13G/A
| |
01/24/2020
5:14 AM | Myovant Sciences (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13G/A
| |
01/16/2020
4:28 PM | Myovant Sciences (Issuer)
Sablich Kim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2020
7:42 AM | Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
| Form SC 13D
| |
01/03/2020
5:02 PM | Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2020
7:05 AM | Myovant Sciences (Filer)
| Form DEF 14C
| |
12/31/2019
3:45 PM | Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2019
3:45 PM | Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
| Form SC 13D/A
| |
12/30/2019
6:14 PM | Lang Matthew (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2019
6:13 PM | KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2019
4:15 PM | Myovant Sciences (Issuer)
Nomura Hiroshi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/30/2019
4:13 PM | Gulfo Adele M. (Reporting)
Myovant Sciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/30/2019
8:16 AM | Myovant Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2019
3:06 PM | Myovant Sciences (Filer)
| Form PRE 14C
| |
12/19/2019
3:25 PM | Myovant Sciences (Issuer)
Sablich Kim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2019
3:28 PM | Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2019
5:08 PM | Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2019
3:45 PM | Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
| Form SC 13D/A
| |
11/27/2019
3:45 PM | Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
8:28 PM | Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
7:56 AM | Myovant Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2019
7:40 AM | Myovant Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2019
5:05 AM | Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
| Form SC 13D/A
| |
10/31/2019
8:24 AM | Myovant Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2019
4:06 PM | Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
| Form SC 13D/A
| |
08/27/2019
3:59 PM | Myovant Sciences (Issuer)
Sablich Kim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
3:58 PM | Lang Matthew (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
3:55 PM | KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
3:53 PM | Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
3:50 PM | Myovant Sciences (Issuer)
Torti Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
3:48 PM | Myovant Sciences (Issuer)
Sebelius Kathleen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
3:46 PM | Myovant Sciences (Issuer)
POTTER MYRTLE S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
3:44 PM | GUINAN MARK (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
3:42 PM | Curran Terrie (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
3:06 PM | Myovant Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2019
4:03 PM | Myovant Sciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/06/2019
3:33 PM | Myovant Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/25/2019
3:05 PM | Myovant Sciences (Filer)
| Form DEF 14A
| |
07/16/2019
4:29 PM | Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
| Form SC 13D/A
| |
07/15/2019
8:37 PM | Lo Andrew (Reporting)
Myovant Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
